Care of Patients with Liver Disease during the COVID-19 Pandemic
This lay summary for patients and their associations serves as a guidance from the “EASL–ESCMID Position Paper” and intended to be consulted alongside local and national guidance about COVID-19. It outlines:
• how healthcare providers are minimising COVID-19 transmission
• what changes to expect in your care during the pandemic
• what to expect if you get COVID-19
• prioritisation of patients for some tests and procedures
The lay summary was published together with the accompanying COVID-19 Toolkit for liver patient organisations. They were written as a collaboration among patient organisations, advisory groups, and EASL board members, and are based on the “ESCMID–EASL Position Paper”, originally published in the Journal of Hepatology.